Position in NVO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$3,161,602
-$2,218,550 QoQ
Shares Held
86,030
-18.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bulltick Wealth Management, LLC holds $5,539,170 across 8 Drug Manufacturers - General names. NVO ranks #1 (57.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
86,030 | $3,161,602 | |
| 2 | PFE |
Pfizer Inc
|
22,859 | $641,880 | |
| 3 | ABBV |
AbbVie Inc.
|
1,721 | $374,300 | |
| 4 | LLY |
ELI LILLY & Co
|
364 | $334,796 | |
| 5 | SNY |
Sanofi
|
6,818 | $328,491 | |
| 6 | JNJ |
Johnson & Johnson
|
1,334 | $326,082 | |
| 7 | GSK |
GSK plc
|
3,693 | $203,816 | |
| 8 | GRFS |
Grifols SA
|
20,973 | $168,203 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,161,602 | 86,030 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,380,152 | 105,742 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,761,205 | 157,888 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,207,252 | 60,957 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $276,579 | 3,983 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $563,258 | 6,548 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,714,745 | 31,198 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||